Christian M. Jespersen

High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease

Jens Kastrup, Julia S. Johansen, Per Winkel et al. · European Heart Journal · 2009 · 159 citations · Full text

Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial

Christian M. Jespersen, Bodil Als‐Nielsen, Morten Damgaard et al. · BMJ · 2005 · 153 citations · Full text

Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: A randomized, placebo-controlled, multicenter clinical trial

Keyvan Karkouti, Christian von Heymann, Christian M. Jespersen et al. · Journal of Thoracic and Cardiovascular Surgery · 2013 · 85 citations · Full text

Cardiac Surgery, Recombinant Factor Xiii, Cardiovascular Disease +9

Clarithromycin for 2 Weeks for Stable Coronary Heart Disease: 6-Year Follow-Up of the CLARICOR Randomized Trial and Updated Meta-Analysis of Antibiotics for Coronary Heart Disease

Christian Gluud, Bodil Als‐Nielsen, Morten Damgaard et al. · Cardiology · 2008 · 59 citations · Full text

Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer

Ravi Gill, Nancy A. Nussmeier, Peter Skov Olsen et al. · Thrombosis and Haemostasis · 2009 · 46 citations